Skip to content

CapEx at other companies

NeoGenomics logo
NeoGenomicsNEO
$8.22M+30.0%
Illumina logo
IlluminaILMN
$38M+18.8%
Veracyte logo
VeracyteVCYT
$2.96M+62.8%
Biodesix, Inc. logo
Biodesix, Inc.BDSX
$81K+9.5%
Adaptive Biotechnologies logo
Adaptive BiotechnologiesADPT
$796K-36.8%
Personalis, Inc. logo
Personalis, Inc.PSNL
$3.19M+27.1%

Other financials

Income statement

See full
Revenue$301.7M+48.3%
Gross profit$196.7M+52.8%
Operating income-$121.4M-9.3%
Net income-$112.1M-17.8%
EPS (diluted)-$0.85-10.4%

Balance sheet

See full
Cash & equivalents$1.1B+37.0%
Total debt$1.7B+30.5%
Total equity-$181.1M+27.8%
Total assets$1.9B+42.5%

Cash flow

See full
Operating cash flow-$65.6M-4.7%
Free cash flow-$71.2M-6.0%

Valuation

See full
Market cap$19.04B+255%
Enterprise value$19.65B+229%
P/S17.6×+11.2×

Profitability

See full
Gross margin64.9%+3.6pp
Operating margin-41.4%-9.4pp
Net margin-40.1%-8.1pp
FCF margin-22%-6.7pp

Returns & leverage

See full
Return on equity-438.1%-1,655pp
Debt / equity
Current ratio4.7×+0.6×

Where this comes from

Reported directly by Guardant Health in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

The official record: Guardant Health’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Guardant Health's capex.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Guardant Health's capex?
Guardant Health (GH) reported capex of $5.58M in Q1 2026.
How has Guardant Health's capex changed year-over-year?
Guardant Health's capex increased by 25.1% year-over-year, from $4.46M to $5.58M.
What is the long-term trend for Guardant Health's capex?
Over 4 years (2021 to 2025), Guardant Health's capex has grown at a -10.4% compound annual growth rate (CAGR), from $75.04M to $48.31M.
What does capex mean?
Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.